When developing a new product in-house and introducing it to a CMO, when is the Product development report (PDR) typically approved? Would it be prior to building engineering batches at the CMO? Is it considered good practice to leave it in draft until just before submission of the regulatory filing?
Want to stay in touch with the latest updates from Pharmaguideline Forum - Latest posts? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.
Reading your RSS feed has never been easier!
Website title: Pharmaguideline Forum - Pharmaceutical Help